Inventia Life Science Accelerates Growth With $25M Series B And Launches 3D Cell Culture Platform Into Us Market
Amount Raised
$25 Million
Round Type
Series B
SydneyBiotechnologyScience And EngineeringDescription
Inventia Life Science, a world leader in advanced 3D cell cultures for research and clinical purposes, has today announced the close of a US $25M Series B funding round, led by Blackbird Ventures. Inventia has also announced the launch of its US operations with the appointment of Dwayne Dexter as its Director of US Sales. Through this Series B round of financing, Inventia plans to market its RASTRUMTM 3D cell culture platform worldwide and grow its team from 36 to 150 employees by the end of 2024. In particular, it aims to develop a strong presence in the US, where the biomedical research and drug discovery markets are currently estimated to be worth more than US $40 billion
Quick answer
Inventia Life Science raised $25 Million in a Series B round, dated December 15, 2021. Inventia Life Science is based in Sydney, New South Wales, Australia.
- How much did Inventia Life Science raise?
- Inventia Life Science raised $25 Million in a Series B round on December 15, 2021.
- What does Inventia Life Science do?
- At Inventia, we’re creating some of the most powerful tools for advanced biomedical discovery today.
- Where is Inventia Life Science based and how big is it?
- Inventia Life Science is based in Sydney, New South Wales, Australia.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Inventia Life Science that raised within 45 days of this round, from Fundz verified event records.
- Kula Bio raised $50M on January 28, 2022.
- Kula Bio raised $50M (Series A) on January 27, 2022.
- Septerna raised $100M (Series A) on January 27, 2022.
- Kyverna Therapeutics raised $85M (Series B) on January 26, 2022.
- Advanced NanoTherapies raised $9.2M on January 26, 2022.
- Leyden Labs raised $200M (Funding Round) on January 25, 2022.
Who to call at Inventia Life Science, and when
A new round usually means Inventia Life Science is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Inventia Life Science raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inventia Life Science, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inventia Life Science. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inventia Life Science raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansInventia Life Science raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.